106 related articles for article (PubMed ID: 29960770)
1. Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.
Breugom AJ; Bastiaannet E; Boelens PG; Van Eycken E; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Ortiz H; Janciauskiene R; Dekkers OM; Rutten HJT; Liefers GJ; Lemmens VEPP; van de Velde CJH
Eur J Surg Oncol; 2018 Sep; 44(9):1338-1343. PubMed ID: 29960770
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania.
Breugom AJ; Bastiaannet E; Boelens PG; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Van Eycken E; Janciauskiene R; Liefers GJ; Cervantes A; Lemmens VE; van de Velde CJ
Eur J Cancer; 2016 Aug; 63():110-7. PubMed ID: 27299663
[TBL] [Abstract][Full Text] [Related]
3. Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.
Claassen YHM; Vermeer NCA; Iversen LH; van Eycken E; Guren MG; Mroczkowski P; Martling A; Codina Cazador A; Johansson R; Vandendael T; Wibe A; Moller B; Lippert H; Rutten HJT; Portielje JEA; Liefers GJ; Holman FA; van de Velde CJH; Bastiaannet E
Br J Cancer; 2018 Aug; 119(4):517-522. PubMed ID: 30057408
[TBL] [Abstract][Full Text] [Related]
4. Differences in pre-operative treatment for rectal cancer between Norway, Sweden, Denmark, Belgium and the Netherlands.
van den Broek CB; van Gijn W; Bastiaannet E; Møller B; Johansson R; Elferink MA; Wibe A; Påhlman L; Iversen LH; Penninckx F; Valentini V; van de Velde CJ;
Eur J Surg Oncol; 2014 Dec; 40(12):1789-96. PubMed ID: 25454831
[TBL] [Abstract][Full Text] [Related]
5. Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group.
Derks MGM; Bastiaannet E; Kiderlen M; Hilling DE; Boelens PG; Walsh PM; van Eycken E; Siesling S; Broggio J; Wyld L; Trojanowski M; Kolacinska A; Chalubinska-Fendler J; Gonçalves AF; Nowikiewicz T; Zegarski W; Audisio RA; Liefers GJ; Portielje JEA; van de Velde CJH;
Br J Cancer; 2018 Jul; 119(1):121-129. PubMed ID: 29875471
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.
van Erning FN; Rutten HJ; van den Berg HA; Lemmens VE; van Halteren HK
Eur J Surg Oncol; 2015 Dec; 41(12):1630-5. PubMed ID: 26437853
[TBL] [Abstract][Full Text] [Related]
7. North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis.
Claassen YHM; Dikken JL; Hartgrink HH; de Steur WO; Slingerland M; Verhoeven RHA; van Eycken E; de Schutter H; Johansson J; Rouvelas I; Johnson E; Hjortland GO; Jensen LS; Larsson HJ; Allum WH; Portielje JEA; Bastiaannet E; van de Velde CJH
Eur J Surg Oncol; 2018 Dec; 44(12):1982-1989. PubMed ID: 30343998
[TBL] [Abstract][Full Text] [Related]
8. One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.
Bahadoer RR; Bastiaannet E; Claassen YHM; van der Mark M; van Eycken E; Verbeeck J; Guren MG; Kørner H; Martling A; Johansson R; van de Velde CJH; Dekker JWT
Eur J Surg Oncol; 2021 Jul; 47(7):1651-1660. PubMed ID: 33518367
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies and survival of older breast cancer patients - an international comparison between the Netherlands and Ireland.
Kiderlen M; Walsh PM; Bastiaannet E; Kelly MB; Audisio RA; Boelens PG; Brown C; Dekkers OM; de Craen AJ; van de Velde CJ; Liefers GJ
PLoS One; 2015; 10(2):e0118074. PubMed ID: 25646756
[TBL] [Abstract][Full Text] [Related]
10. Effect of preoperative treatment strategies on the outcome of patients with clinical T3, non-metastasized rectal cancer: A comparison between Dutch and Canadian expert centers.
Breugom AJ; Vermeer TA; van den Broek CB; Vuong T; Bastiaannet E; Azoulay L; Dekkers OM; Niazi T; van den Berg HA; Rutten HJ; van de Velde CJ
Eur J Surg Oncol; 2015 Aug; 41(8):1039-44. PubMed ID: 26059312
[TBL] [Abstract][Full Text] [Related]
11. Treatment and Survival of Patients with Colon Cancer Aged 80 Years and Older: A EURECCA International Comparison.
Vermeer NCA; Claassen YHM; Derks MGM; Iversen LH; van Eycken E; Guren MG; Mroczkowski P; Martling A; Johansson R; Vandendael T; Wibe A; Moller B; Lippert H; Portielje JEA; Liefers GJ; Peeters KCMJ; van de Velde CJH; Bastiaannet E
Oncologist; 2018 Aug; 23(8):982-990. PubMed ID: 29567826
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
[TBL] [Abstract][Full Text] [Related]
13. European quality assurance programme in rectal cancer--are we ready to launch?
Mroczkowski P; Ortiz H; Penninckx F; Påhlman L
Colorectal Dis; 2012 Aug; 14(8):960-6. PubMed ID: 21973222
[TBL] [Abstract][Full Text] [Related]
14. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
[TBL] [Abstract][Full Text] [Related]
15. Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.
Claassen YHM; Bastiaannet E; van Eycken E; Van Damme N; Martling A; Johansson R; Iversen LH; Ingeholm P; Lemmens VEPP; Liefers GJ; Holman FA; Dekker JWT; Portielje JEA; Rutten HJ; van de Velde CJH
Eur J Surg Oncol; 2019 Aug; 45(8):1396-1402. PubMed ID: 31003722
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in the treatment of rectal cancer: a population based study.
Martling A; Granath F; Cedermark B; Johansson R; Holm T
Eur J Surg Oncol; 2009 Apr; 35(4):427-33. PubMed ID: 18436417
[TBL] [Abstract][Full Text] [Related]
18. Short-term results and long-term oncologic outcomes between neoadjuvant chemoradiotherapy and adjuvant postoperative chemoradiotherapy for stage III rectal cancer: a case-matched study.
Kang J; Jang SM; Baek JH; Lee WS; Cho TH
Ann Surg Oncol; 2012 Aug; 19(8):2494-9. PubMed ID: 22476817
[TBL] [Abstract][Full Text] [Related]
19. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
20. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
